Pittsburgh scientists develop possible coronavirus vaccine, hope FDA can fast-track it
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of UPMC
A microneedle array, a patch about the size of a fingertip, would be used to deliver the covid-19 vaccine developed by Pitt researchers.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
Courtesy of University of Pittsburgh
Scientists at the University of Pittsburgh School of Medicine announced Thursday that a vaccine against the novel coronavirus, when tested in mice, produces antibodies specific to the SARS-CoV-2 that could be enough to fight off the virus.
